Key result
CORM-2 allosterically inhibits the Kv2.1 channel by uncoupling voltage-sensor activation from channel opening.
CORM-2 is identified as an allosteric inhibitor of Kv2.1 and Shaker K+ channels, providing a useful tool for studying electromechanical coupling in voltage-activated channels.
No clinical implications yet; extends tools for probing Kv channel electromechanical coupling in preclinical models.
The Kv2.1 channel generates a delayed-rectifier current in neurons and is responsible for modulation of neuronal spike frequency and membrane repolarization in pancreatic β-cells and cardiomyocytes. As with other tetrameric voltage-activated K(+)-channels, it has been proposed that each of the four Kv2.1 voltage-sensing domains activates independently upon depolarization, leading to a final concerted transition that causes channel opening. The mechanism by which voltage-sensor activation is coupled to the gating of the pore is still not understood. Here we show that the carbon-monoxide releasing molecule 2 (CORM-2) is an allosteric inhibitor of the Kv2.1 channel and that its inhibitory properties derive from the CORM-2 ability to largely reduce the voltage dependence of the opening transition, uncoupling voltage-sensor activation from the concerted opening transition. We additionally demonstrate that CORM-2 modulates Shaker K(+)-channels in a similar manner. Our data suggest that the mechanism of inhibition by CORM-2 may be common to voltage-activated channels and that this compound should be a useful tool for understanding the mechanisms of electromechanical coupling.
No takes yet. Share an insight, caveat, or question.
Jara-Oseguera et al. (2011) studied this question. CORM-2 (carbon-monoxide releasing molecule 2) was evaluated on Inhibition of Kv2.1 channel and uncoupling of voltage-sensor activation from opening transition. CORM-2 acts as an allosteric inhibitor of the Kv2.1 channel by reducing the voltage dependence of the opening transition and uncoupling voltage-sensor activation from channel opening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: